Although the mislocalization of AQP4 was proposed to be a mechanism of alleviating benign disease, such as autoimmune mediated CNS pathophysiology, it may also be useful for designing anticancer therapeutic targets (141–143). This evidence concerns the gene AQP4 and neoplasm.